Ajanta Pharma retains the tag of fastest wealth creator for the third time in a row and Asian Paints is the most consistent wealth creator, said the wealth creation study
The pharma company had posted strong fourth quarter profits but margins had contracted. The R&D spend for the quarter stood at 9 percent, says Yogesh M Agrawal, Managing Director of the company.
Sunil Duggal, CEO of Dabur India, in an interview with CNBC-TV18’s Sonia Shenoy and Anuj Singhal, spoke about the recent 30-Plus agreement that they have acquired with Ajanta Pharma and shared his gave view on the road ahead.